By Tina Peng ( June 10, 2009, 12:00 AM EDT) -- A federal appeals court has nixed some of the costs awarded to Daiichi Pharmaceutical Co. Ltd. after it won a patent dispute over its antibiotic drug Levaquin against Mylan Laboratories Inc., citing the fact that Mylan shared discovery costs with another generics maker in a separate infringement suit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.